INS and obesity disorder: The key advantage of this model is to mimic the slow pathogenesis of type 2 diabetes that occurs in humans, encompassing the slow development from adult-onset diet-induced obesity to glucose intolerance, insulin resistance, the resulting compensatory insulin release and finally STZ-induced partial β-cell death.